Target intelligence / Profile preview

Importin-5 (IPO5)

Target
IPO5
Molecular classification
Transporter, Nuclear import receptor, Karyopherin family
01

Overview

Importin-5 is a member of the importin beta (karyopherin) family of nuclear transport receptors encoded by the IPO5 gene. It facilitates the nuclear import of cargo proteins with a nuclear localization signal (NLS) by binding these cargo proteins in the cytoplasm, docking at the nuclear pore complex, and enabling their import into the nucleus in a process regulated by the small GTPase Ran and nucleoside triphosphates[1][2][3]. Importin-5 plays a critical role in shuttling ribosomal proteins, histones H3/H4 (especially monomeric H3), and various viral proteins between cytoplasm and nucleus[2][3][5]. In oncology, importin-5 is of interest due to its aberrant overexpression in certain cancers and its centrality to protein trafficking that supports cell growth and survival[3]. It also functions in viral infection, as several viruses (e.g., HIV, HPV, influenza) hijack this pathway for nuclear import of their proteins. No selective clinically approved drugs target IPO5 directly, and disrupting its activity carries significant safety risks due to its fundamental roles in normal cell function[3][5].

Other names
Ran-binding protein 5 (RanBP5)Importin beta-3 (KPNB3)Karyopherin subunit beta 3Karyopherin beta 3
02

Mechanism of action

Mediates nuclear import by binding proteins with nuclear localization signals (NLS); releases cargo upon RanGTP binding; proteins utilize IPO5 for entry into the nucleus, including viral proteins (e.g., HIV-1 Rev, HPV16 E5) and cellular proteins (e.g., ribosomal proteins, histones)[2][3][5].

03

Biological functions

Nuclear protein importRegulation of cellular protein localizationRegulation of cell signalingNuclear import of histonesRegulation of gene expressionViral protein nuclear import
04

Disease associations

CancerInfection (notably in viral replication)Other (potential links to genetic disorders such as Gapo syndrome)
05

Safety considerations

Modulation of importin-5 could disrupt essential nucleocytoplasmic protein transport, raising concerns of off-target toxicity and disruption of cellular homeostasis[3]
06

Biomarkers

IPO5 overexpression (potential biomarker in cancers)

Beyond the preview

Go deeper on Importin-5 (IPO5).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Importin-5 (IPO5).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call